Clinical Trial Update: HSK7653 Metformin Add-on Study in Patients With Type 2 Diabetes Mellitus [Phase 3]

View source ↗

Summary

Phase 3 trial of HSK7653 as add-on to metformin in type 2 diabetes completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• HSK7653
• metformin (metformin)

Snippet

Sponsor: Sichuan Haisco Pharmaceutical Group Co., Ltd | Conditions: Diabetes Mellitus, Type 2 | Phase 3 | Status: COMPLETED